Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandre Harlé

Showing results (21-30 of 64) with videos related to

Pageof 7
Sort By:
International Journal of Molecular Sciences|June 1, 2019
Dual Epigenetic Regulation of ERα36 Expression in Breast Cancer CellsCharlène Thiebaut, Amand Chesnel, Jean-Louis Merlin, et al.
Pharmaceuticals (Basel, Switzerland)|August 28, 2021
Epithelial to Mesenchymal Transition in Patients with Pancreatic Ductal Adenocarcinoma: State-of-the-Art and Therapeutic OpportunitiesJulie Dardare, Andréa Witz, Jean-Louis Merlin, et al.
Cancers|November 14, 2023
<i>ESR1</i> Gene Mutations and Liquid Biopsy in ER-Positive Breast Cancers: A Small Step Forward, a Giant Leap for Personalization of Endocrine Therapy?Margaux Betz, Vincent Massard, Pauline Gilson, et al.
Scientific Reports|May 19, 2021
Evaluation of the Idylla ctEGFR mutation assay to detect EGFR mutations in plasma from patients with non-small cell lung cancersPauline Gilson, Chloé Saurel, Julia Salleron, et al.
Virchows Archiv : an International Journal of Pathology|February 13, 2013
Comparison of COBAS 4800 KRAS, TaqMan PCR and high resolution melting PCR assays for the detection of KRAS somatic mutations in formalin-fixed paraffin embedded colorectal carcinomasAlexandre Harlé, Benoit Busser, Marie Rouyer, et al.
Biomedicines|December 23, 2023
Integrated Molecular Characterization of HER2-Low Breast Cancer Using Next Generation Sequencing (NGS)Jean-Louis Merlin, Marie Husson, Nassim Sahki, et al.
Molecular Diagnosis & Therapy|January 29, 2017
Comparison of Five Different Assays for the Detection of BRAF Mutations in Formalin-Fixed Paraffin Embedded Tissues of Patients with Metastatic MelanomaClaire Franczak, Julia Salleron, Cindy Dubois, et al.
Plos One|April 26, 2016
Detection of BRAF Mutations Using a Fully Automated Platform and Comparison with High Resolution Melting, Real-Time Allele Specific Amplification, Immunohistochemistry and Next Generation Sequencing Assays, for Patients with Metastatic MelanomaAlexandre Harlé, Julia Salleron, Claire Franczak, et al.
Biomarker Research|February 22, 2025
Homologous recombination deficiency (HRD) testing landscape: clinical applications and technical validation for routine diagnosticsAndréa Witz, Julie Dardare, Margaux Betz, et al.
Oncotarget|September 6, 2018
Accelerated <i>BRAF</i> mutation analysis using a fully automated PCR platform improves the management of patients with metastatic melanomaDelphine Serre, Julia Salleron, Marie Husson, et al.
Pageof 7

Showing results (21-30 of 64) with videos related to

Sort By:
Pageof 7
International Journal of Molecular Sciences|June 1, 2019
Dual Epigenetic Regulation of ERα36 Expression in Breast Cancer CellsCharlène Thiebaut, Amand Chesnel, Jean-Louis Merlin, et al.
Pharmaceuticals (Basel, Switzerland)|August 28, 2021
Epithelial to Mesenchymal Transition in Patients with Pancreatic Ductal Adenocarcinoma: State-of-the-Art and Therapeutic OpportunitiesJulie Dardare, Andréa Witz, Jean-Louis Merlin, et al.
Cancers|November 14, 2023
<i>ESR1</i> Gene Mutations and Liquid Biopsy in ER-Positive Breast Cancers: A Small Step Forward, a Giant Leap for Personalization of Endocrine Therapy?Margaux Betz, Vincent Massard, Pauline Gilson, et al.
Scientific Reports|May 19, 2021
Evaluation of the Idylla ctEGFR mutation assay to detect EGFR mutations in plasma from patients with non-small cell lung cancersPauline Gilson, Chloé Saurel, Julia Salleron, et al.
Virchows Archiv : an International Journal of Pathology|February 13, 2013
Comparison of COBAS 4800 KRAS, TaqMan PCR and high resolution melting PCR assays for the detection of KRAS somatic mutations in formalin-fixed paraffin embedded colorectal carcinomasAlexandre Harlé, Benoit Busser, Marie Rouyer, et al.
Biomedicines|December 23, 2023
Integrated Molecular Characterization of HER2-Low Breast Cancer Using Next Generation Sequencing (NGS)Jean-Louis Merlin, Marie Husson, Nassim Sahki, et al.
Molecular Diagnosis & Therapy|January 29, 2017
Comparison of Five Different Assays for the Detection of BRAF Mutations in Formalin-Fixed Paraffin Embedded Tissues of Patients with Metastatic MelanomaClaire Franczak, Julia Salleron, Cindy Dubois, et al.
Plos One|April 26, 2016
Detection of BRAF Mutations Using a Fully Automated Platform and Comparison with High Resolution Melting, Real-Time Allele Specific Amplification, Immunohistochemistry and Next Generation Sequencing Assays, for Patients with Metastatic MelanomaAlexandre Harlé, Julia Salleron, Claire Franczak, et al.
Biomarker Research|February 22, 2025
Homologous recombination deficiency (HRD) testing landscape: clinical applications and technical validation for routine diagnosticsAndréa Witz, Julie Dardare, Margaux Betz, et al.
Oncotarget|September 6, 2018
Accelerated <i>BRAF</i> mutation analysis using a fully automated PCR platform improves the management of patients with metastatic melanomaDelphine Serre, Julia Salleron, Marie Husson, et al.
Pageof 7